KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Procter & Gamble (PG) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Procter & Gamble's Capital Expenditures rose 2616.22% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.2 billion, marking a year-over-year increase of 2069.75%. This contributed to the annual value of $3.8 billion for FY2025, which is 1357.62% up from last year.
  • Latest data reveals that Procter & Gamble reported Capital Expenditures of $1.2 billion as of Q4 2025, which was up 2616.22% from $1.2 billion recorded in Q3 2025.
  • Procter & Gamble's Capital Expenditures' 5-year high stood at $1.2 billion during Q3 2025, with a 5-year trough of $626.0 million in Q4 2021.
  • For the 5-year period, Procter & Gamble's Capital Expenditures averaged around $852.5 million, with its median value being $807.0 million (2023).
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 2835.29% in 2021, then plummeted by 1842.35% in 2022.
  • Procter & Gamble's Capital Expenditures (Quarter) stood at $626.0 million in 2021, then rose by 13.1% to $708.0 million in 2022, then rose by 15.4% to $817.0 million in 2023, then grew by 13.22% to $925.0 million in 2024, then grew by 26.16% to $1.2 billion in 2025.
  • Its Capital Expenditures was $1.2 billion in Q4 2025, compared to $1.2 billion in Q3 2025 and $996.0 million in Q2 2025.